Entos Pharmaceuticals

Provider of nanotech-based drug delivery solutions

placeEdmonton, Alberta, Canada calendar_todayFounded 2016 groups41 employees language entospharma.com

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 274 times.

YearFilings
20171
20181
20192
20202
20211
20223
20235
20245
20255

Social engagement

Social engagement: 8.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Bank & private debt120%
Other / undisclosed360%

Recent activity

25 Jun 2026
Partnership
SwedenBIO
23 Jun 2026
Event
BIO2026
17 Jun 2026
Event
BIO International Convention 2026
Coming soon